The risk of neurologic adverse events was 41% lower in patients treated with immune checkpoint inhibitors than in patients who received another drug regimen or a placebo.
Multiple myeloma (MM) forms in a patient’s plasma cells, and the symptoms it brings can affect their quality of life in ways they may not be thinking about when first diagnosed. What are some lifestyle factors that are affected by multiple myeloma, and how can you discuss managing them with your patients?
Rates of SARS-CoV-2 neutralizing antibodies are significantly higher with the Moderna vaccine than with the Pfizer-BioNTech vaccine in patients with multiple myeloma.